About AIT Bioscience
AIT Bioscience is a company based in Indianapolis (United States) founded in 2009 was acquired by Nexelis in July 2020. AIT Bioscience has raised $1.5 million across 2 funding rounds from investors including Nexelis. AIT Bioscience operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
- Headquarter Indianapolis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ait Bioscience, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AIT Bioscience
AIT Bioscience has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AIT Bioscience
AIT Bioscience has secured backing from 1 investor. Prominent investors backing the company include Nexelis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Assay development and bioanalytical services are provided worldwide.
|
Locked | Locked | Locked |
Investor details for AIT Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AIT Bioscience
Investment portfolio details for AIT Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AIT Bioscience
Detailed financials for AIT Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ait Bioscience Comparisons
Peer comparison for AIT Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AIT Bioscience
AIT Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
Detailed competitors of AIT Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ait Bioscience
Complete news archive for AIT Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AIT Bioscience
AIT Bioscience was founded in 2009 and raised its 1st funding round 5 years after it was founded.
AIT Bioscience is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
AIT Bioscience is a funded company, having raised a total of $1.5M across 2 funding rounds to date.
AIT Bioscience offers bioanalytical contract research services for pre-clinical and phase I to III clinical trials. The company provides drug discovery analysis, protein analysis, and uses ligand-binding assays to provide immunogenicity information to support clinical and non-clinical studies. It employs electronic systems that detect and resolve potential deviations and errors in real time. The company has significant expertise in LC-MSMS based techniques and has a collaboration with Crown Bioscience, an in vivo, drug discovery CRO for a 3-way study relationship. The company also claims to be the first CRO to go completely paperless.
AIT Bioscience's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
AIT Bioscience has 1 investor. Key investors include Nexelis.